Kiyoshi Ashida

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of <scp>TAK</scp>‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects

Helen Jenkins, Yuichi Sakurai, Akira Nishimura et al. · Alimentary Pharmacology & Therapeutics · 2015 · 307 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis

Kiyoshi Ashida, Yuichi Sakurai, Tetsuharu Hori et al. · Alimentary Pharmacology & Therapeutics · 2015 · 301 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis

Kiyoshi Ashida, Yuichi Sakurai, Akira Nishimura et al. · Alimentary Pharmacology & Therapeutics · 2015 · 190 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects

Yuuichi Sakurai, Akira Nishimura, Gale Kennedy et al. · Clinical and Translational Gastroenterology · 2015 · 190 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients With Functional Dyspepsia: A Randomized Controlled Trial

Hiroto Miwa, Akihito Nagahara, Kazunari Tominaga et al. · The American Journal of Gastroenterology · 2009 · 142 citations

Medicine, Pharmacology, Pharmacotherapy +14